NPC
GSK icon

National Planning Corporation’s GSK GSK Stock Holding History

National Planning Corporation’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8,935
Closed -$453K – 265
2017
Q3 		$453K Sell
8,935
-1,114
-11% -$56.5K 0.04% 389
2017
Q2 		$537K Buy
10,049
+1,611
+19% +$85.9K 0.04% 388
2017
Q1 		$443K Sell
8,438
-631
-7% -$32K 0.03% 411
2016
Q4 		$446K Buy
9,069
+465
+5% +$23K 0.03% 402
2016
Q3 		$418K Buy
8,604
+330
+4% +$18.1K 0.03% 398
2016
Q2 		$470K Buy
8,274
+1,309
+19% +$69K 0.04% 390
2016
Q1 		$367K Sell
6,965
-3,782
-35% -$188K 0.03% 431
2015
Q4 		$548K Buy
10,747
+5,094
+90% +$260K 0.04% 382
2015
Q3 		$301K Sell
5,653
-10,738
-66% -$559K 0.03% 461
2015
Q2 		$917K Sell
16,391
-1,735
-10% -$97.7K 0.08% 233
2015
Q1 		$1.03M Sell
18,126
-25
-0.1% -$1.43K 0.09% 207
2014
Q4 		$955K Buy
18,151
+5,443
+43% +$305K 0.07% 255
2014
Q3 		$727K Sell
12,708
-9,604
-43% -$589K 0.06% 316
2014
Q2 		$1.49M Buy
22,312
+143
+0.6% +$9.68K 0.12% 181
2014
Q1 		$1.47M Buy
22,169
+1,958
+10% +$132K 0.13% 168
2013
Q4 		$1.34M Buy
20,211
+5,992
+42% +$389K 0.12% 188
2013
Q3 		$898K Buy
14,219
+2,938
+26% +$189K 0.09% 236
2013
Q2 		$698K Buy
+11,281
New +$716K 0.09% 234

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

National Planning Corporation's GSK Position: Q4 2017 in Review

National Planning Corporation sold out of GSK (GSK) in Q4 2017, closing a stake of 8,935 shares — an estimated $453K sold.

National Planning Corporation first reported a position in GSK in Q2 2013 and held it in 18 quarters. The position peaked at $1.49M in Q2 2014. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • National Planning Corporation reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 8,935 GSK shares in Q4 2017, an estimated $453K.
  • National Planning Corporation first reported a position in GSK in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's GSK position peaked at $1.49M in Q2 2014.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.